Literature DB >> 31236666

Renal failure, respiratory distress, and an atypical purpuric rash in a full-term infant with omphalocele and hypospadias: Answers.

Aaron J Weiss1,2, Kenny Kronforst3,4.   

Abstract

Entities:  

Keywords:  Atypical HUS; Complement factor H (CFH); Complement-mediated HUS; Eculizumab; Infant; Neonate

Mesh：

Substances：

Year:  2019        PMID： 31236666     DOI： 10.1007/s00467-019-04275-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  17 in total

1.  Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

Authors:  Jessica Caprioli; Marina Noris; Simona Brioschi; Gaia Pianetti; Federica Castelletti; Paola Bettinaglio; Caterina Mele; Elena Bresin; Linda Cassis; Sara Gamba; Francesca Porrati; Sara Bucchioni; Giuseppe Monteferrante; Celia J Fang; M K Liszewski; David Kavanagh; John P Atkinson; Giuseppe Remuzzi
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

2.  Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

Authors:  Marina Noris; Jessica Caprioli; Elena Bresin; Chiara Mossali; Gaia Pianetti; Sara Gamba; Erica Daina; Chiara Fenili; Federica Castelletti; Annalisa Sorosina; Rossella Piras; Roberta Donadelli; Ramona Maranta; Irene van der Meer; Edward M Conway; Peter F Zipfel; Timothy H Goodship; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

3.  Complications of apheresis in children.

Authors:  Bruno Michon; Albert Moghrabi; Rochelle Winikoff; Stéphane Barrette; Mark L Bernstein; Josette Champagne; Michèle David; Michel Duval; Heather A Hume; Nancy Robitaille; André Bélisle; Martin A Champagne
Journal:  Transfusion       Date:  2007-10       Impact factor: 3.157

Review 4.  Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.

Authors:  Elena Bresin; Erica Daina; Marina Noris; Federica Castelletti; Rumen Stefanov; Prudence Hill; Timothy H J Goodship; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2005-11-02       Impact factor: 8.237

5.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

Authors:  Véronique Fremeaux-Bacchi; Fadi Fakhouri; Arnaud Garnier; Frank Bienaimé; Marie-Agnès Dragon-Durey; Stéphanie Ngo; Bruno Moulin; Aude Servais; François Provot; Lionel Rostaing; Stéphane Burtey; Patrick Niaudet; Georges Deschênes; Yvon Lebranchu; Julien Zuber; Chantal Loirat
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-10       Impact factor: 8.237

6.  Non-enteropathic hemolytic uremic syndrome: causes and short-term course.

Authors:  Alex R Constantinescu; Martin Bitzan; Lynne S Weiss; Erica Christen; Bernard S Kaplan; Avital Cnaan; Howard Trachtman
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

7.  Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.

Authors:  Sheena Sharma; Madhura Pradhan; Kevin E C Meyers; Krisha Le Palma; Benjamin L Laskin
Journal:  Clin Nephrol       Date:  2015-09       Impact factor: 0.975

8.  Eculizumab Dosing in Infants.

Authors:  M Kobrzynski; B Wile; S S Huang; G Filler
Journal:  Indian J Nephrol       Date:  2018 Jan-Feb

Review 9.  Atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Tim H Goodship; Anna Richards
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

10.  Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment.

Authors:  Johan Vande Walle; Yahsou Delmas; Gianluigi Ardissino; Jimmy Wang; John F Kincaid; Herman Haller
Journal:  J Nephrol       Date:  2016-03-19       Impact factor: 3.902
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.